Advisor Group’s GenMark Diagnostics GNMK Stock Holding History
Bought
Maintained
Sold
Other funds holding GNMK
Advisor Group's GNMK Position: Q4 2019 in Review
Advisor Group increased its GenMark Diagnostics (GNMK) stake by 44% in Q4 2019, buying an estimated $7.18K and bringing the position to 4,264 shares worth $21K. The position accounts for ﹤0.01% of the portfolio, ranked #3944.
Advisor Group first reported a position in GNMK in Q3 2018 and has held it in 6 quarters since. 111 funds tracked by Wall St. Rank hold GNMK as of Q4 2019.
- Advisor Group held 4,264 shares of GenMark Diagnostics worth $21K as of Q4 2019.
- Advisor Group bought 1,302 GenMark Diagnostics shares in Q4 2019, an estimated $7.18K.
- GenMark Diagnostics made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #3944 holding.
- Advisor Group first reported a position in GenMark Diagnostics in Q3 2018 and has held it in 6 quarters since.
- 111 funds tracked by Wall St. Rank held GenMark Diagnostics as of Q4 2019.
Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.